RESEARCH LETTER
 
TOPICS
REFERENCES (27)
1.
Chen W, Liu L, Hu F. Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: an updated systematic review and meta‐analysis of randomized controlled trials. Diabetes Obes Metabol 2024; 26: 5713-26.
 
2.
Sun Y, Zhang H, Wang B, et al. Serum 25-hydroxyvitamin D, genetic susceptibility, and the risk of incident type 2 diabetes: a prospective cohort in East China. Chin Med J 2024; 137: 972-9.
 
3.
Gallagher JC, Rosen CJ. Vitamin D: 100 years of discoveries, yet controversy continues. Lancet Diabetes Endocrinol 2023; 11: 362-74.
 
4.
Virtanen JK, Nurmi T, Aro A, et al. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial. Am J Clin Nutr 2022; 115: 1300-10.
 
5.
Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019; 380: 33-44.
 
6.
Thompson B, Waterhouse M, English DR, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ 2023; 381: e075230.
 
7.
Yang Y, Liu J. What can we learn from the vitamin D and type 2 diabetes (D2d) study? J Diabetes 2020; 12: 259-61.
 
8.
Giampazolias E, Pereira da Costa M, Lam KC, et al. Vitamin D regulates microbiome-dependent cancer immunity. Science 2024; 384: 428-37.
 
9.
Delrue C, Speeckaert MM. Vitamin D and vitamin D-binding protein in health and disease. Int J Mol Sci 2023; 24: 4642.
 
10.
Qin L, Zhang H, Li Q, et al. Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma. Theranostics 2024; 14: 436-50.
 
11.
Wong THT, Luo S, Au Yeung SL, Louie JCY. Association between coffee consumption and metabolic syndrome: a cross‐sectional and Mendelian randomization study. J Diabetes 2024; 16: e70004.
 
12.
Xing X, Wang Y, Pan F, Cai G. Osteoarthritis and risk of type 2 diabetes: a two‐sample Mendelian randomization analysis. J Diabetes 2023; 15: 987-93.
 
13.
Lawler T, Warren Andersen S. Serum 25-hydroxyvitamin D and cancer risk: a systematic review of mendelian randomization studies. Nutrients 2023; 15: 422.
 
14.
Revez JA, Lin T, Qiao Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun 2020; 11: 1647.
 
15.
Albiñana C, Zhu Z, Borbye-Lorenzen N, et al. Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots. Nat Commun 2023; 14: 852.
 
16.
The GTEx Consortium, Aguet F, Anand S, Ardlie KG, et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 2020; 369: 1318-30.
 
17.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613: 508-18.
 
18.
Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 2023; 4: 186.
 
19.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-8.
 
20.
Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet 2016; 48: 481-7.
 
21.
Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103: 239-51.
 
22.
Brust LA, Linxweiler M, Schnatmann J, et al. Effects of vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas. Biomed Pharmacother 2024; 180: 117497.
 
23.
Zhang S, Jiang L, Cai S, et al. Vitamin D binding protein, a ligand of integrin beta 1, motivates both tumor cells and schwann cells to promote perineural invasion in pancreatic ductal adenocarcinoma. Adv Sci 2025:.
 
24.
Sheeley MP, Andolino C, Kiesel VA, Teegarden D. Vitamin D regulation of energy metabolism in cancer. Br J Pharmacol 2022; 179: 2890-905.
 
25.
Jiang X, Dimou NL, Al-Dabhani K, et al. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol 2019; 48: 1416-24..
 
26.
Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 2019; 381: 520-30.
 
27.
Sisley SR, Arble DM, Chambers AP, et al. Hypothalamic vitamin D improves glucose homeostasis and reduces weight. Diabetes 2016; 65: 2732-41.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top